Exact Sciences
EXAS
#1548
Rank
$11.17 B
Marketcap
$60.37
Share price
-0.63%
Change (1 day)
-6.55%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Net assets

Net assets on the balance sheet as of September 2024 : $3.21 Billion USD

According to Exact Sciences's latest financial reports the company has $3.21 Billion USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Exact Sciences - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$$3.14 B3.36%
2022-12-31$$3.04 B-10.17%
2021-12-31$$3.38 B51.53%
2020-12-31$$2.23 B-2.29%
2019-12-31$$2.28 B236.01%
2018-12-31$$0.68 B30.85%
2017-12-31$$0.52 B55.21%
2016-12-31$$0.33 B2.58%
2015-12-31$$0.32 B13.11%
2014-12-31$$0.28 B113.56%
2013-12-31$$0.13 B37.24%
2012-12-31$$98.59 M18.08%
2011-12-31$$83.49 M4.69%
2010-12-31$$79.75 M1208.73%
2009-12-31$$6.09 M-350.47%
2008-12-31$-$2.44 Million-138.69%
2007-12-31$$6.28 M-57.96%
2006-12-31$$14.95 M-39.25%
2005-12-31$$24.62 M-35.18%
2004-12-31$$37.98 M210.62%
2003-12-31$$12.22 M-68.11%
2002-12-31$$38.34 M-34.97%
2001-12-31$$58.96 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
$0.73 B-77.21%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.17 B-63.37%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.29 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
$78.25 B 2,337.36%๐Ÿ‡ซ๐Ÿ‡ท France